UpdatesPress Release
Bajaj Healthcare reported FY26 revenue up 12.6% to Rs 611.03 Cr, driven by strong API exports and formulations.
Bajaj Healthcare LimitedBAJAJHCARE · Filed with the exchange
PAT from continuing operations grew 27.1% to Rs 54.56 Cr.
Q4 faced API price erosion.
The company raised Rs 52.7 Cr for growth and is advancing new CNS drugs.
No comments yet. Be the first.